|
|
Article: Adimab Completes Series D Financing Led by Google Ventures.
- Article from:
- Biotech Week
- Article date:
- October 14, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Adimab, Inc., a world leader in human antibody discovery, announced the closing of a Series D financing led by Google Ventures with participation by previous investors Polaris Ventures, SV Life Sciences, OrbiMed Advisors and Borealis Ventures. Bill Maris of Google Ventures will join Adimab's Board of Directors. The total amount of the financing was not disclosed (see also Adimab, Inc.).
"Cutting-edge life science technologies are extremely computationally intensive, and Google Ventures will contribute valuable input as Adimab works to become the world's leading antibody discovery company," said Bill Maris, Managing Partner at Google Ventures. "Adimab's technology ...
Related newspaper, magazine, and journal articles:
|
|
Article: Adimab Announces Scientific Advisory Board Members.
Business Wire;
November 1, 2007 ;
544 words
...LEBANON, N.H. -- Adimab, Inc. today announced the initial ... scientists, whose expertise relates well to Adimab's efforts to utilize yeast as a single ... and expression," said Dane Wittrup, Adimab Chairman of the Scientific Advisory ...
|
|